Novartis AG is 88.4x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($282.64 B vs $3.20 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TLX | NVS |
|---|---|---|
| Market cap | $3.20 B | $282.64 B |
| US-listed rank | #1752 | #47 |
| SEC filings | 95 | 947 |
Novartis AG is 88.4x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($282.64 B vs $3.20 B).
Full pages: Telix Pharmaceuticals Ltd and Novartis AG, or browse the full rankings.